ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,596Medicare Part D Prescriptions Filled, Including Refills

Rank: 356 out of 4623

$820K Total Retail Price of All Prescriptions

Rank: 253 out of 4623

310 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
82% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

8% of this provider’s 310 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 10,602 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

31% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$71 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

37 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
NAMENDA 590 576 1 36
METOPROLOL TARTRATE 411 378 2 9
DONEPEZIL HCL 409 391 3 30
LEVOTHYROXINE SODIUM 366 358 4 1
SIMVASTATIN 350 295 5 2
FUROSEMIDE 274 261 6 8
NOVOLIN R 271 239 7 113
OMEPRAZOLE 262 227 8 7
POTASSIUM CHLORIDE 234 221 9 14
AMLODIPINE BESYLATE 230 212 10 5
OLANZAPINE 227 223 11 127
METFORMIN HCL 198 155 12 6
METOPROLOL SUCCINATE 166 163 13 13
LISINOPRIL 164 157 14 4
CIPROFLOXACIN HCL 159 141 15 43
ALBUTEROL SULFATE 149 147 16 142
QUETIAPINE FUMARATE 146 133 17 74
EXELON 134 132 18 107
LANTUS 123 101 19 44
CARBIDOPA-LEVODOPA 123 123 19 116
ESCITALOPRAM OXALATE 122 110 21 75
WARFARIN SODIUM 120 120 22 24
CLONIDINE HCL 114 80 23 40
TAMSULOSIN HCL 111 107 24 29
HYDROCHLOROTHIAZIDE 111 93 24 10
TRAMADOL HCL 109 92 26 15
MUPIROCIN 109 102 26 159
RAMIPRIL 102 90 28 76
NOVOLOG 100 88 29 123
MIRTAZAPINE 98 97 30 57
CITALOPRAM HBR 96 84 31 23
AZITHROMYCIN 91 79 32 33
CLOPIDOGREL 88 78 33 31
LISINOPRIL-HYDROCHLOROTHIAZIDE 86 82 34 19
ATORVASTATIN CALCIUM 83 69 35 12
ZOLPIDEM TARTRATE 80 76 36 18
HYDRALAZINE HCL 78 39 37 99
CLOTRIMAZOLE-BETAMETHASONE 75 73 38 147
PHENYTOIN SODIUM EXTENDED 74 49 39 119
DIOVAN 74 73 39 39
RISPERIDONE 73 73 41 72
GLIPIZIDE 71 55 42 49
PANTOPRAZOLE SODIUM 71 62 42 35
NEXIUM 67 62 44 17
IPRATROPIUM BROMIDE 66 66 45 216
SEROQUEL 66 62 45 149
DIGOXIN 65 65 47 58
CRESTOR 64 62 48 20
LOSARTAN POTASSIUM 62 50 49 21
HYDROCODONE-ACETAMINOPHEN 61 54 S3 50 3
FAMOTIDINE 61 57 50 82
LEVEMIR 61 61 50 154
PLAVIX 57 49 53 45
PHENYTOIN 55 44 54 294
ENALAPRIL MALEATE 53 53 55 41
HUMULIN R 52 49 56 252
CYMBALTA 52 41 56 48
CEFDINIR 52 49 56 129
IBUPROFEN 50 28 59 65
CARVEDILOL 50 50 59 25
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 21, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.